cutaneous telangiectasia and hemorrhage from nasal and gastrointestinal vascular beds. Nosebleeds (epiTo identify mutations that cause hereditary hemorrhagic staxes) are usually the earliest clinical symptom, mucotelangiectasia (HHT, or Rendu-Osler-Weber syncutaneous telangiectases develop in approximately onedrome), clinical evaluations and genetic studies were third of cases at age õ30 years, whereas anemia due performed on 32 families. Linkage studies in four of to gastrointestinal bleeding occurs later in life. Twenty eight families indicated an endoglin (ENG) gene muta-percent of affected individuals (Plauchu et al. 1989) detion. ENG sequences of affected members of the four velop pulmonary arteriovenous malformations linked families and probands from the 24 small families (PAVMs), which may result in hypoxemia, and parawere screened for mutations, by Southern blot analyses doxical embolism. and by cycle sequencing of PCR-amplified DNA. Seven
To better understand the relationship between ENG dom hexanucleotide labeling (Boehringer-Mannheim) (Ausubel et al. 1989) . Clone 104 contained the 3 exons mutations and the incidence of PAVMs and to elucidate the mechanism by which ENG mutations cause HHT, of ENG and a novel CA repeat described below. P1 rearrangements were excluded by both analysis of genowe studied 32 HHT families. ENG sequences were screened for defects in probands from 28 families; and mic DNA and agreement with the AK1 fragment sizes predicted by the GenBank sequence. in 8 families a causal mutation was identified. Affected individuals from these eight families exhibited comparaLinkage Analyses ble clinical features of HHT, indicating little effect of genotype on the variable phenotype of HHT. FurtherSix polymorphic loci, ordered D9S60/D9S315/AK1/ ENG/SPTAN/D9S61, span 2 cM on chromosome 9q more, two of the mutations demonstrated a marked reduction in ENG transcription from the mutant allele, (Shovlin et al. 1995a) . Linkage studies were performed as described elsewhere (Shovlin et al. 1994a) , by use of thereby providing information on the molecular mechanism of HHT pathogenesis.
published sequences to amplify D9S60, D9S315, D9S61 (GenBank), and AK1 (Puffenberger and Francomano 1991) . Two novel CA repeats associated with P1 clones Material and Methods containing ENG and SPTAN were identified in P1 Clinical Evaluations clones by use of Quick Light (Life-Codes) probes and protocols. The primer sequences, derived by vectoretteAll studies were performed with the approval of local mediated PCR (Edwards et al. 1991 ) of P1 clones, were committees for research on human subjects. Thirty-two ENG-CA 5atctcagctactgtgagctgaggca and 5aagccccac-study families of northern-European descent were idenggacagcactgga and SPTAN-CA 5accgtgttagccaggatg-tified when one affected member was referred to a tergtcttga and 5tatccccagcactttgcatggtattt. ENG-CA has tiary-care hospital (Hammersmith Hospital, London) four alleles, size 215-221 bp and PIC .35; SPTAN-CA for therapy. Referrals were usually for PAVMs; five proamplified three alleles, size 185-193 bp and PIC .26. bands were referred for other HHT manifestations. Clinical evaluations, including history, physical examina-ENG Primer Sequences tion, and portable oximetry to screen for PAVMs All ENG cDNA primers (C1-C19) were derived from (Chilvers et al. 1990) , were performed on all available the published GenBank (NIH sequence databases) ENG family members of each proband, by C.L.S. Additional cDNA sequence (GenBank accession number X72012) medical history was obtained from patient records. Diand are described in the legend to figure 1. Intronic agnostic criteria for disease status have been described primers (E1 forward-E14 reverse; fig. 2 ) were derived elsewhere (Shovlin et al. 1994a) .
either from the work of McAllister et al. (1994) or by Genetic Analyses sequencing templates derived from the P1 clones, including subclones, long-PCR products, inverse-PCR temGenomic DNA was derived from peripheral blood, as plates (Ausubel et al. 1989) , vectorette (''bubble'')-medidescribed elsewhere (Shovlin et al. 1994a) . mRNA was ated PCR (Edwards et al. 1991) , and alu-exon PCR prepared from Epstein-Barr virus (EBV)-transformed products, by use of alu primers complementary to the lymphoblastoid lines (Ausubel et al. 1989) or from reverse 5 and forward 3 of the Alu consensus sequence: buffy-coat leukocyte preparations from 10 ml of fresh Tagle3 (gatcgcgccactgcactcc) and alu450 (aaagtgctgggablood by use of RNAzol TM (Cinna Biotecx). ENG cDNA ttacagg). was transcribed from these templates by Moloney murine leukemia virus reverse transcriptase (Gibco BRL) ENG-Mutation Screens (Ausubel et al. 1989) P-labeled C1/C12 PCR product. PCR products spanning exons or groups of exons were Four clones containing ENG were identified from a pAd10sacBII (''P1'') library of human genomic DNA screened for mutations, by manual cycle sequencing. ENG sequences were amplified from genomic DNA or (DuPont-Merck), as described elsewhere . Clone 22 contained the entire coding sequence of ENG cDNA templates by use of a final 25-ml PCR reaction composed of 0.6 units of rTth DNA polymerase XL and the adjacent adenylate kinase 1 gene (AK1). The clone was characterized further by Southern blots using (Perkin Elmer), 85 mM potassium acetate, 25 mM tricine pH 8.7, 8% glycerol, 1% dimethylsulfoxide (XL either PCR-amplified ENG exons (Saiki et al. 1988) ENG cDNA structure and the exons that encode it. The location of oligonucleotide primers used to amplify ENG sequences are indicated (arrows). The number and order of exons are as described by McAllister et al. (1994) and our unpublished data; for each exon, the last nucleotide is numbered according to GenBank accession number X72012. The variably retained intron (13A) between exons 13 and 14 (shaded) encodes the ENG-S form (Bellon et al. 1993 Since HHT can be caused by mutations in more than one gene, linkage analyses were initially performed in for 10 min. Exons 1 and 3 required an annealing step of 58ЊC, including, for exon 1, a step-down procedure the study families whose size was sufficient to provide information. Linkage studies excluded an ENG mutafrom an initial temperature of 68ЊC (Hecker and Roux 1996) . The quality of PCR-amplified products was as-tion in four families (families S, T, V, and Y; LOD score õ01.32); HHT in four families (A, B, F, and W; LOD sessed by agarose-gel electrophoresis. The Cyclist TM Taq DNA sequencing kit (Stratagene) was used to sequence score ú1.32) was linked to the ENG locus on chromosome 9 (table 1) . DNA samples from probands of the 4 2 ml of PCR products directly: gel purification was required only for early Taq PCR products in unnested families whose HHT was linked to chromosome 9 and from probands from the remaining 24 small HHT famisequencing reactions or to separate wild-type and mutant alleles, as an alternative to T-vector cloning lies were studied further.
Figure 2
Schematic of ENG spanning 35 kb, and expanded view of the 11 kb spanning exons 4-14. Restriction-enzyme sites are indicated as follows: B Å BamHI; X Å XhoI; H Å HindIII; E Å EcoRI; x Å XbaI; P Å PstI; and b Å BglI. Arrows represent the position and orientation of the alu elements flanking exon 8. Exons were amplified with intronic primers E2 forward and reverse, E4 forward and reverse, E5 forward, E6 forward and reverse, E7 forward and reverse, E10 reverse, E11 forward and reverse, E12 forward and reverse, and E13 forward, described by McAllister et al. (1994) . In addition intronic primers E1 forward (ccagccccttctctaaggaa), E1 reverse (tccccaccctgggtccctggaca), E3 forward (aacctatacaaatctgact), E3 reverse (tgacagtaggacttcccat), E5 reverse (tctcgggntggggactagtgtca), E8 forward (gccgcctggcctgcctctgcta), E8 reverse (tgagcnngaggggcaggagtt), E9 forward (aatggctgtgacttgggacccctg), E9A reverse (gacaacagctggtcctgatac), E9B reverse (aggagtttcccgaggcctgctccca), and E14 reverse (aatgtcactgcccttctcccagc) were used. Exons 9A, 9B, and 10 were amplified by use of E9 forward/E10 reverse (or, for exon 10, by use of C13/E10 reverse), and exons 13, 13A, and 14 were amplified by use of E13 forward/E14 reverse.
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07-07-97 10:31:41 ajhga UC-AJHG ENG Structure and Transcripts HHT families ( fig. 3 ). These defects included four deletions and three point mutations, one shared by two famiAs a first step toward identification of HHT mutalies. tions, the ENG structure ( fig. 2 ) and RNA transcripts Southern blot analyses of the proband in family R were characterized. Distances between exons were as-( fig. 4Ai ) demonstrated a mutant allele that deleted sessed by use of long PCR (only the first and second Ç1.5 kb of DNA, spanning exon 8 and the flanking introns were not spanned by this method) and were intronic sequences. The introns flanking exon 8 were refined by restriction mapping of P1 clone 22. ENG found to contain alu sequences ( fig. 2, arrows) , the site spans Ç35 kb and is organized into 15 exons. ENG and orientation of which could account for the delesequences previously assigned (McCallister et al. 1994) tion by homologous recombination, as has been deto exons 8 and 9 were found to be organized into three scribed for other sequences containing alu repeats exons. Exon 8 contains nucleotides 1391-1415. Exon (Shovlin et al. 1994b ). The deletion in family R results 9 sequences are contained in two exons, here designated in a mutant ENG transcript ( fig. 5Aii ) that lacks exon ''9A'' and ''9B.'' Exon 9B contains only 39 bp. Compari-8 and, because of a frameshift, predicts the incorporason of ENG mRNA transcripts and genomic structure tion of 25 novel amino acids before a TGA stop codon demonstrated that the long (L-ENG) and short (S-ENG) is reached in exon 9A. forms of ENG protein (Bellon et al. 1993 ) result from An ENG deletion was also found in family I. Southern alternative splicing of the final intron between exons 13 blot analyses identified a large deletion extending from and 14 (designated ''13A'').
intron 8, deleting exons 9A-14 ( fig. 4B ). Although the Two polymorphisms were mapped during these studies.
3 boundary of the deletion has not been defined, it The RFLPs in AK1 (Puffenberger and Francomano 1991) does not extend to an ENG CA repeat located õ60 were identified on the same EcoRI fragment as was ENG kb distant, since affected family members demonstrate exon 1. Furthermore, a novel CA-dinucleotide repeat was heterozygosity at this polymorphism. In addition to prolocated õ60 kb from ENG exon 14.
tein-encoding sequences, this mutation deletes the ENG ENG Mutations polyadenylation addition site, thereby predicting that no stable mRNA species would result. RT-PCR (data not ENG was analyzed in probands from 28 HHT families, by three independent methods: Southern blot analy-shown) of samples from affected family members failed to amplify product from the mutant allele; only wildses, genomic amplification and sequencing of each exon, and reverse transcription of ENG mRNA and PCR am-type ENG cDNA was detected; that is, ENG mRNA was reversed transcribed (see Material and Methods), plification of ENG cDNA (rt-PCR) for sequence analysis (Methods). Novel mutations were identified in eight PCR amplified, and cloned into a plasmid vector, and the clones were characterized by nucleotide-sequence analysis; no mutant ENG cDNA clones were detected, and only wild-type ENG cDNA clones were found. The deletion mutation in family B was first detected Table 1 as a short cDNA species: sequencing of this product amino acids Arg-Thr-Leu-Glu-Trp-Arg-Pro. Four of between HHT and ENG in families A, F, and T have been described these residues are highly conserved ENG transcripts seelsewhere (Shovlin et al. 1994a ).
quenced from man, mouse, and pig ( fig. 6 ).
a Markers were selected because they were informative in the fami-
The HHT disease haplotype (loci D9S315/ENG/ lies. All markers are õ2 cM of ENG (Shovlin et al. 1995a; authors' unpublished data) .
SPTAN, õ2 cM from ENG) segregating in families F
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Figure 3
Pedigrees of HHT families. Individuals are designated by sex, disease status (blackened symbols denote affected individuals, and unblackened symbols denote unaffected individuals), and pedigree numbers. Deceased individuals are denoted by diagonal slashes. M Å presence of ENG mutation causing HHT. Asterisks (*) denote living individuals who did not participate in genetic studies.
and N was the same, suggesting that these two families, cryptic splice site shares only 5 of the 11 residues of the optimal donor splice-site consensus sequence, C/AAGwhich are of similar southern-English ancestry and currently reside Ç100 miles apart, share a founding muta-GTT/ATGTAT (Zhang et al. 1995) . However, an adjacent polypurine tract comprising nucleotides 1397-tion that arose in a shared ancestor. This hypothesis was confirmed by sequence analyses of ENG in the probands 1406 may enhance the use of this splicing site (Laviguer et al. 1993; Manley and Tacke 1996) and thereby acof families F and N, which demonstrated that these individuals shared the same HHT-causing mutation. A GrA count for the absence of transcripts that lack exon 8 sequences. substitution was identified in the donor splice signal of intron 8 ( fig. 4A ) in affected individuals from both fam-A donor splice-site mutation was also detected in family O. The ArG substitution in intron 3 was identiily F and family N. Although this gene defect might generate several ENG transcripts because of exon skip-fied by genomic sequencing (data not shown). Although there is a potential cryptic donor splice site ping and/or use of cryptic splice sites, only one abnormal cDNA species was amplified by PCR. The mutant, trun-upstream (nucleotides 560 -571) that contains 7 of 11 residues of the optimal donor splice-site consensus secated ENG transcript lacked 24 nucleotides (1391-1415) that encode eight poorly conserved amino acids quence, this did not appear to be active. RT-PCR using primers C2 and C7 amplified only one mutant tran-( fig. 6 ). These nucleotides, encoded in exon 8 ( fig. 1) , are deleted from the mutant cDNA sequence by activascript, which lacked exon 3 ( fig. 4B ). This mutant transcript predicts the loss of 47 amino acids from the tion of a cryptic splice site within exon 8, located 24 nucleotides upstream from the natural splice site. This translated protein.
/ 9a2d$$jy26
07-07-97 10:31:41 ajhga UC-AJHG
Figure 4
ENG deletions causing HHT in four families. DNA samples from affected individuals (lanes A) and unaffected individuals (lanes /) were analyzed. Ai, HindIII digest of genomic DNA from individuals in family R. A Southern blot filter probed with PCR product which spans exon 7. The shorter HindIII fragment is due to a deletion, which also created a novel PstI fusion fragment of 2 kb, by the apposition of the truncated fragment containing exons 7 and 8 (5) to a fragment normally 3 of exon 8. Aii, C8/C12 RT-PCR (using primers C8 and C12), demonstrating the wild-type product (502 bp) and a shorter product (363 bp) that lacked all exon 8 sequence. B, Genomic Southern blot of samples from family I. EcoRI-digested DNA was probed with PCR products containing exon 8 (E8 forward/E8 reverse) and exon 14 (E13 forward/E14 reverse). Although these exons lie on the same EcoRI fragment, in DNA from affected individuals a small fragment detected by the exon 8 probe was not detected by the exon 14 probe, indicating that the deletion includes exon 14. The larger XbaI fragment defines the 5 extent of the deletion, since intron 8 normally contains an XbaI site (data not shown). Ci, Genomic Southern blot of samples from family B. DNA samples were digested with HindIII, and the filter was probed sequentially with PCR products containing a part of the 5 region of ADA on chromosome 20 (Shovlin et al. 1994b ) and with exon 2 (E2 forward and reverse). Quantitative assessment of these and additional data not illustrated, by use of a Molecular Dynamics Phosphorimager TM (model 4255) and the ImageQuant TM program, confirmed that the ENG exon 2 bands from affected individuals were half the predicted intensity, compared with those in equally loaded wild-type controls. Cii, RT-PCR (using primers C2 and C7), which amplified the wild-type product (603 bp) and a shorter fragment (310 bp) that lacked exon 2 nucleotides. D, Exon 5 amplified from genomic DNA in samples from family Q (E5 forward and reverse). The 283-bp product results from a 21-bp genomic deletion.
Affected members of family AA were heterozygous than 100 normal chromosomes were screened for each of these seven ENG defects; no defects were detected. for a CrT substitution at residue 792 in exon 4 ( fig.  4A ). This mutation changes the normal CGA codon
We conclude that these ENG defects caused HHT in each family. (encoding arginine) to a TGA stop codon. mRNAs derived from either peripheral blood lymphocytes or Two additional sequence variants were identified. These appear to be rare polymorphisms in ENG, rather EBV-transformed lymphoblast cell lines derived from two affected family members were amplified by RTthan disease-causing mutations. Members of one family were heterozygous for the transition C295T, which al-PCR using poly(dT) 14 and primer C14 ( fig. 1) . The amplified PCR product was subjected to sequence ters a nonconserved codon, in exon 1, from ACG (threonine) to ATG (methionine). However, this allele did not analysis to determine the ratio of mutant and wildtype cDNA. In three independent analyses, only wildsegregate with disease. In another family, C401T was present only in an affected father and daughter but did type sequence was detected. Absence of the mutated transcript may reflect early degradation of mRNAs not predict an amino acid substitution. Two further silent nucleotide variations were found to be polymorphic containing nonsense codons (Belgrader and Maquat 1994) , especially because residues 758 -771 (tgctgain the normal population: G488A in exon 2 (in 11% of the control population) and C1310T in exon 8 (in 5% gctgaatg) have homology to a Saccharomyces cerevisiae sequence that is responsible for premature mRNA of the control population). Southern blot analyses and sequence analyses of ENG degradation (Zhang et al. 1995) .
Only one ENG defect was identified in affected exons and cDNAs failed to identify ENG mutations in two families (A and W), although, in each of them, members from these eight families. There was complete concordance between the clinical status of family genetic studies indicated linkage between HHT and the ENG locus (LOD scores ú3, u Å 0). We suspect that members and the presence of each ENG defect. More / 9a2d$$jy26 07-07-97 10:31:41 ajhga UC-AJHG
Figure 5
ENG point mutations causing HHT in four families. A, ENG transcripts, amplified by use of primers C8 and C12 ( fig. 1 ), from affected members of families F and N, revealing the normal sized product (293 bp) and a truncated product (269 bp) resulting from a GrA splice-site mutation and use of a cryptic splice site. The genomic mutation is indicated, and the polypurine tract is underlined. B, ArG splice site mutation identified in family O, which produces a truncated transcript that lacks exon 3. RT-PCR (using primers C2 and C7) amplified the wild-type 520-bp product and the mutant 379-bp product. C, T lane of dideoxy sequence reactions, for DNA samples from three affected members of family AA and for one control sample. Note the absence of the band in the T lane (residue 792) in the control sample.
an undetected 5 deletion, possibly involving ENG profrom both families were heterozygous for the ENG CA repeat (data not shown). moter sequences, may account for HHT in family W, since affected members have only one allele at each AK1 Clinical Data polymorphism. Large deletions that might mutate important 3 ENG sequences appear to be an unlikely
The clinical manifestations of HHT (table 2) that are associated with these novel ENG mutations were comcause of HHT in either family, since affected members
Figure 6
Human, mouse, and pig ENG amino acid sequences in the vicinity of HHT mutations (the sites of the stop codons in exons 3 and 9A, which predict truncated proteins, are not illustrated). The human ENG cDNA is illustrated as in figure 1 and defines the sites of encoded cysteine residues implicated in dimerization (C), as well as the position of the transmembrane domain (TM).
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07-07-97 10:31:41 ajhga UC-AJHG pared. Telangiectases and nosebleeds, often commenc-missed ENG mutations in some families. Taken together, these data suggest that ENG mutations may ing in childhood, were common manifestations of disease in the 30 affected individuals from these eight HHT cause as much as 50% of HHT.
Previous studies have suggested that PAVMs frefamilies. Seven individuals from five families had documented gastrointestinal involvement. Twenty-one indi-quently occurred in HHT patients whose disease was caused by ENG mutations (Guttmacher et al. 1995) . viduals from eight families had PAVMs. Although a larger series (Shovlin et al. 1995b ) suggested an in-In the present study, HHT patients with PAVMs were identified in 19 unrelated families in which no ENG creased incidence of PAVMs in female patients, the presence of PAVMs in affected men or women did not statis-mutations were detected, including affected members of 4 families whose disease did not segregate with the ENG tically differ in this study group. Three women, from families F, I, and O, had pregnancy-related deterioration locus (table 1) . Among the HHT patients studied here, the incidence of PAVMs was higher in those whose disin the pulmonary vascular bed. Parameters analyzed by analysis of variance (computed by use of Statview TM ease was caused by ENG mutations than in those whose disease was caused by mutations in other HHT disease MII) did not demonstrate differences-with respect to age of presentations, subjective severity of nose bleeds genes.
Characterization of HHT-causing mutations provides or telangiectasia, or PAVMs-in HHT caused by the seven different ENG mutations.
insights into the molecular mechanism by which ENG mutations cause HHT, and it may provide novel apThe incidence of PAVMs in individuals whose disease was caused by ENG mutations and in individuals whose proaches for therapeutic development. ENG is expressed as a disulfide-linked dimer on endothelial cells. Predisease was not caused by ENG mutations was assessed (table 2 and data not shown). Forty-one percent (23/56) viously reported mutations predicted defects in the peptide's extracellular domain, and a dominant negative of HHT patients with ENG mutations had PAVMs, whereas a significantly smaller fraction, 14% (5/35), of mechanism has been proposed (McAllister et al. 1995) to account for the pathogenesis of HHT. ENG deficiency HHT patients in whom linkage analyses indicated non-ENG mutations had PAVMs (P õ .01).
has also been postulated to cause HHT, via a somatic, second event (a ''two-hit'' mechanism; McAllister et al. 1994) . The data presented here demonstrate that mutations that block ENG mRNA production can also cause We have characterized the structure of ENG, defined the alternative splice variants that result in L-ENG and HHT. We conclude that haploinsufficiency of ENG can cause HHT. S-ENG, and identified seven novel mutations that cause HHT in eight families. Two point mutations result in
Discussion
The lack of correlation between genotype and clinical manifestations of HHT supports the haploinsufficiency aberrant splicing. A third, which would predict premature termination in exon 4, was not detected in cDNA model. If a dominant-negative mechanism accounted for HHT, different mutations might be expected to be assopreparations. Four deletions were also identified, and at least one of these appears to function as a null allele. ciated with discrete clinical phenotypes. In contrast, if HHT mutations result in ENG haploinsufficiency, it These seven mutations have not been described elsewhere, and we did not detect in the 32 HHT study would be surprising if clinical features were mutation specific. In our series, the clinical phenotypes (table 2) families any of the ENG defects reported elsewhere (McAllister et al. 1994 (McAllister et al. , 1995 . A greater diversity of caused by seven mutations were not statistically different. Furthermore, the greatest trend toward differences different types of ENG mutations were identified in the present study than in previous studies, presumably be-in visceral involvement was observed between families F and N, which share the identical ENG mutation. cause of the comprehensive screening methods that we applied, rather than because of differences in patient How does the loss of ENG protein result in HHT? The majority of vascular beds in which ENG is expressed populations. cDNA analyses proved to be the most informative approach and identified five of the seven mu- (Cheifetz et al. 1992) appear to develop normally in HHT patients, implying that the quantitative requiretations; three of seven mutations would have been entirely missed without cDNA screening or without careful ment for ENG varies spatially and, perhaps, temporally.
ENG binds TGF-b1 and -b3 (Cheifetz et al. 1992 ) and analysis for genomic deletions. Despite genomic and cDNA analyses, mutations were defined in only two of can modify a subset of cellular responses to TGF-b1, including the inhibition of cellular proliferation and the four families with HHT linked to ENG. Families with HHT linked to ENG in which mutations were not de-stimulation of extracellular adhesion molecules (Lastres et al. 1996) . There is a wide range of known roles for tected may have defects either in regulatory regions of ENG or in intronic sequences. We have demonstrated the ENG ligands, which in the vasculature include development (Dickson et al. 1995; Kaartinen et al. 1995) , ENG mutations in at least one-quarter of the HHT probands studied here and suggest that we could have angiogenesis (Koh et al. 1995) , and vascular repair (Ma-/ 9a2d$$jy26 07-07-97 10:31:41 ajhga UC-AJHG Table 2 Clinical 
